Nisa Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$84M Sell
693,541
-17,578
-2% -$2.03M 0.31% 33
2025
Q4
$75.4M Buy
711,119
+27,207
+4% +$2.55M 0.25% 44
2025
Q3
$58M Sell
683,912
-125,886
-16% -$10.4M 0.22% 58
2025
Q2
$64.8M Buy
809,798
+132,370
+20% +$10.5M 0.29% 48
2025
Q1
$61.4M Sell
677,428
-184,516
-21% -$17.2M 0.31% 48
2024
Q4
$86.4M Buy
861,944
+52,070
+6% +$5.37M 0.34% 37
2024
Q3
$92.6M Buy
809,874
+98,057
+14% +$11.6M 0.55% 27
2024
Q2
$88.7M Buy
711,817
+3,982
+0.6% +$513K 0.56% 24
2024
Q1
$93.9M Sell
707,835
-11,644
-2% -$1.44M 0.61% 23
2023
Q4
$78.4M Sell
719,479
-30,511
-4% -$3.17M 0.56% 26
2023
Q3
$77.2M Sell
749,990
-7,886
-1% -$850K 0.59% 27
2023
Q2
$87.5M Sell
757,876
-16,270
-2% -$1.85M 0.64% 22
2023
Q1
$82.4M Buy
774,146
+7,711
+1% +$833K 0.65% 21
2022
Q4
$85M Sell
766,435
-693
-0.1% -$70.8K 0.67% 18
2022
Q3
$66.2M Sell
767,128
-11,504
-1% -$1.03M 0.56% 27
2022
Q2
$71M Sell
778,632
-6,707
-0.9% -$595K 0.62% 26
2022
Q1
$64.4M Sell
785,339
-5,671
-0.7% -$447K 0.45% 43
2021
Q4
$64.5M Sell
791,010
-13,334
-2% -$1.06M 0.48% 40
2021
Q3
$60.4K Sell
804,344
-36,793
-4% -$2.8M 0.37% 50
2021
Q2
$65.4K Sell
841,137
-92,530
-10% -$6.88M 0.41% 44
2021
Q1
$68.7K Sell
933,667
-108,137
-10% -$7.98M 0.44% 39
2020
Q4
$81.3M Sell
1,041,804
-163
-0% -$12.5K 0.52% 30
2020
Q3
$82.5M Sell
1,041,967
-6,608
-0.6% -$518K 0.66% 23
2020
Q2
$77.4M Sell
1,048,575
-37,713
-3% -$2.84M 0.71% 22
2020
Q1
$79.8M Sell
1,086,288
-35,843
-3% -$2.82M 0.89% 16
2019
Q4
$97.4M Sell
1,122,131
-4,918
-0.4% -$404K 0.83% 21
2019
Q3
$90.5M Sell
1,127,049
-13,770
-1% -$1.1M 0.8% 22
2019
Q2
$91.3M Sell
1,140,819
-48,686
-4% -$3.73M 0.87% 21
2019
Q1
$94.4M Sell
1,189,505
-515
-0% -$38.5K 0.92% 17
2018
Q4
$86.8M Buy
1,190,020
+24,124
+2% +$1.7M 0.97% 14
2018
Q3
$78.9M Buy
1,165,896
+10,543
+0.9% +$672K 0.72% 24
2018
Q2
$66.9M Buy
1,155,353
+46,867
+4% +$2.64M 0.69% 25
2018
Q1
$57.6M Sell
1,108,486
-40,956
-4% -$2.21M 0.6% 31
2017
Q4
$61.7M Sell
1,149,442
-26,387
-2% -$1.46M 0.64% 29
2017
Q3
$71.8M Sell
1,175,829
-35,292
-3% -$2.14M 0.81% 21
2017
Q2
$74.3M Buy
1,211,121
+32,410
+3% +$1.97M 0.87% 17
2017
Q1
$71.5M Buy
1,178,711
+14,751
+1% +$895K 0.85% 18
2016
Q4
$65.4M Buy
1,163,960
+22,544
+2% +$1.32M 0.79% 19
2016
Q3
$68M Buy
1,141,416
+57,798
+5% +$3.38M 0.88% 16
2016
Q2
$59.6M Buy
1,083,618
+36,648
+4% +$1.95M 0.8% 20
2016
Q1
$52.9M Sell
1,046,970
-26,011
-2% -$1.27M 0.76% 23
2015
Q4
$54.1M Sell
1,072,981
-4,698
-0.4% -$237K 0.77% 23
2015
Q3
$51.1M Sell
1,077,679
-13,022
-1% -$692K 0.78% 18
2015
Q2
$59.3M Sell
1,090,701
-12,157
-1% -$682K 0.84% 16
2015
Q1
$60.5M Buy
1,102,858
+9,926
+0.9% +$562K 0.83% 15
2014
Q4
$59.2M Sell
1,092,932
-133,402
-11% -$7.43M 0.81% 18
2014
Q3
$69.4M Sell
1,226,334
-4,166
-0.3% -$234K 0.97% 13
2014
Q2
$67.9M Sell
1,230,500
-66,786
-5% -$3.64M 0.94% 14
2014
Q1
$70.3M Sell
1,297,286
-13,732
-1% -$711K 1% 14
2013
Q4
$62.6M Sell
1,311,018
-73,860
-5% -$3.38M 0.89% 16
2013
Q3
$62.9M Sell
1,384,878
-61,321
-4% -$2.8M 0.96% 15
2013
Q2
$64.1M Buy
+1,446,199
New +$64.6M 0.99% 17

Other funds holding MRK

Nisa Investment Advisors's MRK Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Merck (MRK) stake by 2.5% in Q1 2026, selling an estimated $2.03M and leaving 693,541 shares worth $84M. The position accounts for 0.31% of the portfolio, ranked #33.

Nisa Investment Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $97.4M in Q4 2019. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Nisa Investment Advisors held 693,541 shares of Merck worth $84M as of Q1 2026.
  • Nisa Investment Advisors sold 17,578 Merck shares in Q1 2026, an estimated $2.03M.
  • Merck made up 0.31% of Nisa Investment Advisors's portfolio in Q1 2026, its #33 holding.
  • Nisa Investment Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's Merck position peaked at $97.4M in Q4 2019.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.